Aon and the European Bank for Reconstruction and Development launch innovative war risk insurance facility for Ukraine
Builds on Aon’s efforts to support Ukraine’s economy, insurance industry and preparation for reconstruction – representing more than $465M in public and private capital for war risk insurance New €110 million guarantee scheme through the EBRD to provide reinsurance capacity for inter
Samsung rolls out enhanced health features for Galaxy Watch users in the Gulf
DUBAI, UAE, Dec. 12, 2024 /PRNewswire/ — Samsung Gulf Electronics has announced the availability of additional health monitoring features on Galaxy Watch devices in the wider Gulf, expanding the range of tools available to the Gulf users. This expansion reflects Samsung’s commitment to
Business of Design Week 2024 Concludes With Over 15,000 in Attendance at Summit
Paving a Design and Innovation-Driven Path Forward to a Sustainable Future with France Italy announced as Partner Country for BODW 2025 HONG KONG, Dec. 12, 2024 /PRNewswire/ — The Business of Design Week 2024 (BODW 2024), Asia’s premier international annual event on design, innovation an
51Talk Online Education Group to Report Third Quarter 2024 Financial Results on Friday, December 13, 2024
Earnings Call Scheduled for 8:00 a.m. ET on December 13, 2024 SINGAPORE, Dec. 12, 2024 /PRNewswire/ — 51Talk Online Education Group (“51Talk”, or the “Company”) (NYSE American: COE), a global online education platform with core expertise in English education, today ann
General Inception acquires Enable Medicine and announces strategic partnership to accelerate drug discovery with AI-led generative biological search
Enable Medicine is at the forefront of using generative AI models to search vast cellular atlases of disease to discover new therapeutic insights Partnership will greatly boost the two companies’ drug discovery and development capabilities It comes after their first collaboration that led to E
SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt Disease
SB-007 is the only IND-cleared, clinical-stage therapeutic addressing the root cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations Phase 1/2 ASTRA study set to begin in the first half of 2025, supported by POLARIS, a pioneering company-sponsored natural his
Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies
New therapies will allow patients greater choice and flexibility in the control of CNS disorders BARCELONA, Spain, DÜSSELDORF, Germany, and ATHENS, Greece, Dec. 12, 2024 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatme
WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection
Leading Green CRDMO Driven by Innovation for a Healthier Future Offering End-to-end Green Biologics Solutions for the Entire Industry SHANGHAI, Dec. 12, 2024 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Or
KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and β-Thalassemia at the 66th American Society of Hematology Meeting and Exposition and Announces FDA Authorization of Investigational New Drug (IND) Application for AND017 for Clinical Trial in Sickle Cell Disease (SCD)
SAN FRANCISCO, Dec. 12, 2024 /PRNewswire/ — Kind Pharmaceutical (“Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC”), a clinical-stage biopharmaceutical company focused on developing innovative medicines to treat hematological diseases and cancers, today announced t
Air France expands network with 3 weekly non-stop flight between Manila and Paris
MANILA, Philippines, Dec. 12, 2024 /PRNewswire/ — Air France has officially inaugurated a new 3 weekly non-stop flight between Manila and Paris on Sunday 8 December. In a pre-departure ribbon-cutting ceremony, Secretary of Transportation, Jaime J. Bautista, Secretary of Tourism, Christina Gar
